Orthofix Medical Inc. Common Stock (DE)
OFIXOrthofix Medical Inc. (OFIX) is a global medical device company specializing in musculoskeletal solutions, including spine, sports, and minimally invasive procedures. Founded in 1987, the company develops and markets products such as spinal implants, devices for bone healing, and treatments for orthopedic conditions, serving physicians and patients worldwide.
Company News
Orthofix Medical reported Q2 2025 financial results, beating earnings estimates with $203.1 million in revenue, representing 2.3% year-over-year growth. The company saw segment gains in Bone Growth Therapies and Orthopedics, with positive free cash flow and continued new product execution.
The global intramedullary nail market is expected to grow rapidly, driven by the rising incidence of bone fractures, particularly among the aging population, and advancements in surgical techniques. However, the market faces challenges such as high procedural costs, the need for skilled professionals, and competition from alternative fixation dev...
The global prosthetic disc nucleus market is expected to grow significantly, driven by the increasing prevalence of spine disorders and the rising demand for minimally invasive spine surgeries. Key players in the market include Zimmer Biomet, Medtronic, Orthofix Holdings, Spinal Kinetics, and Globus Medical.
A class action lawsuit has been filed against Orthofix Medical Inc. and certain current and former officers and directors, alleging that the offering materials for the merger with SeaSpine Holdings Corporation contained materially false and misleading statements and omissions regarding Orthofix's internal controls and compliance.
Bragar Eagel & Squire, P.C. is investigating potential claims against Orthofix Medical Inc. on behalf of long-term stockholders following a class action complaint alleging the company made false and misleading statements about certain members of its management team engaging in inappropriate conduct.
